What Changes Under 2025 ASE Diastolic Function Criteria? - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

What Changes Under 2025 ASE Diastolic Function Criteria?

Researchers evaluated 300,828 adult transthoracic echocardiograms using the 2016 and 2025 American Society of Echocardiography diastolic function guidelines; 87,724 met criteria for analysis.

  • By

  • Kathryn Wighton

  • June 26, 2026

  • 3 min

Share

Clinical Scorecard: What Changes Under 2025 ASE Diastolic Function Criteria?

At a Glance

CategoryDetail
ConditionDiastolic Dysfunction
Key MechanismsEvaluation of diastolic function using echocardiography
Target PopulationAdults undergoing transthoracic echocardiograms
Care SettingEchocardiography laboratories

Key Highlights

  • 20.1% of echocardiograms received different diastolic function grades under 2025 guidelines
  • 14.0% of studies were upgraded in diastolic dysfunction grading
  • 73.8% classified as normal diastolic function under 2025 guidelines
  • Older age, female sex, and higher left ventricular systolic function associated with increased grading
  • Grade 1 diastolic dysfunction increased from 11.9% to 15.7% under new criteria

Guideline-Based Recommendations

Diagnosis

  • Apply 2025 ASE diastolic function grading algorithm for assessment

Management

  • Consider demographic and clinical characteristics in grading

Monitoring & Follow-up

  • Regularly evaluate echocardiograms for changes in diastolic function grading

Risks

  • Increased classification of diastolic dysfunction may affect patient management

Patient & Prescribing Data

Adults with echocardiographic evaluations

Changes in diastolic function grading may influence treatment decisions

Clinical Best Practices

  • Utilize updated guidelines for accurate diastolic function assessment
  • Incorporate demographic factors in echocardiographic evaluations

Related Resources & Content

Original Source(s)

What Changes Under 2025 ASE Diastolic Function Criteria?

  • by Kathryn Wighton

  • June 26, 2026

Related Content

FDA Approves Low-Dose Macrocyclic Contrast Agent for MRI

The macrocyclic gadolinium-based contrast agent has a recommended dose of 0.01 mmol/kg actual body weight.

Synthetic Echo Motion May Aid ECG Risk Modeling

An ensemble electrocardiogram model classified derived diastolic dysfunction risk phenotypes and stratified heart failure–related death risk across external cohorts, according to findings presented at ASE 2026.

ASE Plenary: Progress, Priorities, and What’s Next

Efforts to align, sustain, and engage drove a year of growth for ASE.